ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97–106.
-
2.
Guerra CA, Snow RW, Hay SI, 2006. Mapping the global extent of malaria in 2005. Trends Parasitol 22: 353–358.
-
3.
Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti, Elyazar I, Bangs MJ, Maguire JD, Baird JK, 2007. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 77: 984–991.
-
4.
Rodriguez-Morales AJ, Benitez JA, Arria M, 2008. Malaria mortality in Venezuela: focus on deaths due to Plasmodium vivax in children. J Trop Pediatr 54: 94–101.
-
5.
Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, Muller I, 2008. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 5: e127.
-
6.
Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN, 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5: e128.
-
7.
Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, Kochar A, Khatri MP, Gupta V, 2009. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg 80: 194–198.
-
8.
Garnham PC, 1988. Malaria parasites of man: life cycles and morphology (excluding ultrastructure). Wernsdorfer G, McGregor I, eds. Malaria. Principles and Practice of Malariology. London: Churchill Livingstone, 61–96.
-
9.
Baird JK, 2004. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 48: 4075–4083.
-
10.
Baird JK, Hoffman SL, 2004. Primaquine therapy for malaria. Clin Infect Dis 39: 1336–1345.
-
11.
Rieckmann KH, Davis DR, Hutton DC, 1989. Plasmodium vivax resistance to chloroquine? Lancet 2: 1183–1184.
-
12.
Schuurkamp GJ, Spicer PE, Kereu RK, Bulungol PK, Rieckmann KH, 1992. Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans R Soc Trop Med Hyg 86: 121–122.
-
13.
Baird JK, Basri H, Purnomo, Bangs MJ, Subianto B, Patchen LC, Hoffman SL, 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 44: 547–552.
-
14.
Collignon P, 1991. Chloroquine resistance in Plasmodium vivax. J Infect Dis 164: 222–223.
-
15.
Schwartz IK, Lackritz EM, Patchen LC, 1991. Chloroquine-resistant Plasmodium vivax from Indonesia. N Engl J Med 324: 927.
-
16.
Myat Phone K, Myint O, Myint L, Thaw Z, Kyin Hla A, Nwe Nwe Y, 1993. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans R Soc Trop Med Hyg 87: 687.
-
17.
Guthmann JP, Pittet A, Lesage A, Imwong M, Lindegardh N, Min Lwin M, Zaw T, Annerberg A, de Radigues X, Nosten F, 2008. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar. Trop Med Int Health 13: 91–98.
-
18.
Garg M, Gopinathan N, Bodhe P, Kshirsagar NA, 1995. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg 89: 656–657.
-
19.
Dua VK, Kar PK, Sharma VP, 1996. Chloroquine resistant Plasmodium vivax malaria in India. Trop Med Int Health 1: 816–819.
-
20.
Phillips EJ, Keystone JS, Kain KC, 1996. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis 23: 1171–1173.
-
21.
Alecrim Md G, Alecrim W, Macedo V, 1999. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev Soc Bras Med Trop 32: 67–68.
-
22.
de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, Barbosa MG, Alecrim WD, Alecrim MG, 2007. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis 13: 1125–1126.
-
23.
Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedeno N, Dunne M, Berman J, 2001. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg 65: 90–93.
-
24.
Teka H, Petros B, Yamuah L, Tesfaye G, Elhassan I, Muchohi S, Kokwaro G, Aseffa A, Engers H, 2008. Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia. Malar J 7: 220.
-
25.
Lee KS, Kim TH, Kim ES, Lim HS, Yeom JS, Jun G, Park JW, 2009. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg 80: 215–217.
-
26.
Baird JK, 2007. Neglect of Plasmodium vivax malaria. Trends Parasitol 23: 533–539.
-
27.
Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, 2007. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 79–87.
-
28.
Zhou SS, Wang Y, Tang LH, 2007. Malaria situation in the people's republic of China in 2006 [in Chinese]. Chin J Parasitol Parasitic Dis 25: 439–441.
-
29.
Yang XM, Yang MQ, Huang JW, 1996. Clinical research of the sensitivity of Plasmodium vivax to chloroquine [in Chinese]. Chin J Parasitol Parasitic Dis 9: 226–227.
-
30.
Chotivanich K, Silamut K, Udomsangpetch R, Stepniewska KA, Pukrittayakamee S, Looareesuwan S, White NJ, 2001. Ex-vivo short-term culture and developmental assessment of Plasmodium vivax. Trans R Soc Trop Med Hyg 95: 677–680.
-
31.
Russell BM, Udomsangpetch R, Rieckmann KH, Kotecka BM, Coleman RE, Sattabongkot J, 2003. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob Agents Chemother 47: 170–173.
-
32.
Tasanor O, Noedl H, Na-Bangchang K, Congpuong K, Sirichaisinthop J, Wernsdorfer WH, 2002. An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine. Acta Trop 83: 49–61.
-
33.
Chotivanich K, Udomsangpetch R, Chierakul W, Newton PN, Ruangveerayuth R, Pukrittayakamee S, Looareesuwan S, White NJ, 2004. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. Am J Trop Med Hyg 70: 395–397.
-
34.
Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, Prasetyorini B, Piera KA, Barends M, Brockman A, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN, 2007. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS ONE 2: e1089.
-
35.
Chotivanich K, Sattabongkot J, Choi YK, Park JS, Sritabal J, Lim CS, Udomsangpetch R, White NJ, Lee WJ, 2009. Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg 80: 902–904.
-
36.
Russell B, Chalfein F, Prasetyorini B, Kenangalem E, Piera K, Suwanarusk R, Brockman A, Prayoga P, Sugiarto P, Cheng Q, Tjitra E, Anstey NM, Price RN, 2008. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob Agents Chemother 52: 1040–1045.
-
37.
Sharrock WW, Suwanarusk R, Lek-Uthai U, Edstein MD, Kosaisavee V, Travers T, Jaidee A, Sriprawat K, Price RN, Nosten F, Russell B, 2008. Plasmodium vivax trophozoites insensitive to chloroquine. Malar J 7: 94.
-
38.
Pukrittayakamee S, Imwong M, Looareesuwan S, White NJ, 2004. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop 89: 351–356.
-
39.
Putaporntip C, Hongsrimuang T, Seethamchai S, Kobasa T, Limkittikul K, Cui L, Jongwutiwes S, 2009. Differential prevalence of Plasmodium infections and cryptic Plasmodium knowlesi malaria in humans in Thailand. J Infect Dis 199: 1143–1150.
-
40.
Sattabongkot J, Tsuboi T, Zollner GE, Sirichaisinthop J, Cui L, 2004. Plasmodium vivax transmission: chances for control? Trends Parasitol 20: 192–198.
-
41.
Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ, 1991. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337: 1140–1143.
-
42.
Suwanarusk R, Chavchich M, Russell B, Jaidee A, Chalfein F, Barends M, Prasetyorini B, Kenangalem E, Piera KA, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN, 2008. Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. J Infect Dis 198: 1558–1564.
-
43.
Imwong M, Pukrittayakamee S, Pongtavornpinyo W, Nakeesathit S, Nair S, Newton P, Nosten F, Anderson TJ, Dondorp A, Day NP, White NJ, 2008. Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar. Antimicrob Agents Chemother 52: 2657–2659.
-
44.
Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanonta S, White NJ, 1994. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 88: 324–327.
-
45.
Shen JQ, Hu XS, 1978. Comparison of efficacy between long-term oral administration of pyrimethamine and antimalarial pill 3 [in Chinese]. Railway Med J 2: 90–91.
-
46.
Chen JS, Zhang KR, Geng ZW, 1977. Clinical observation on the in vivo sensitivity of Plasmodium vivax to pyrimethamine in Kaifeng District, Henan Province [in Chinese]. Henan J Prev Med 51–56.
-
47.
Auliff A, Wilson DW, Russell B, Gao Q, Chen N, le Anh N, Maguire J, Bell D, O'Neil MT, Cheng Q, 2006. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am J Trop Med Hyg 75: 617–621.
-
48.
Hawkins VN, Auliff A, Prajapati SK, Rungsihirunrat K, Hapuarachchi HC, Maestre A, O'Neil MT, Cheng Q, Joshi H, Na-Bangchang K, Sibley CH, 2008. Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase. Malar J 7: 72.
-
49.
Vijaykadga S, Rojanawatsirivej C, Congpoung K, Wilairatana P, Satimai W, Uaekowitchai C, Pumborplub B, Sittimongkol S, Pinyorattanachote A, Prigchoo P, 2004. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand. Southeast Asian J Trop Med Public Health 35: 566–569.
-
50.
Tasanor O, Ruengweerayut R, Sirichaisinthop J, Congpuong K, Wernsdorfer WH, Na-Bangchang K, 2006. Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand. Trans R Soc Trop Med Hyg 100: 410–418.
-
51.
Baird JK, Sustriayu Nalim MF, Basri H, Masbar S, Leksana B, Tjitra E, Dewi RM, Khairani M, Wignall FS, 1996. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans R Soc Trop Med Hyg 90: 409–411.
-
52.
Baird JK, Sismadi P, Masbar S, Leksana B, Sekartuti, Ramzan A, Tjitra E, 1996. Chloroquine sensitive Plasmodium falciparum and P. vivax in central Java, Indonesia. Trans R Soc Trop Med Hyg 90: 412–413.
-
53.
Fryauff DJ, Tuti S, Mardi A, Masbar S, Patipelohi R, Leksana B, Kain KC, Bangs MJ, Richie TL, Baird JK, 1998. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am J Trop Med Hyg 59: 513–518.
-
54.
Fryauff DJ, Baird JK, Candradikusuma D, Masbar S, Sutamihardja MA, Leksana B, Tuti S, Marwoto H, Richie T, Romzan A, 1997. Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia. Am J Trop Med Hyg 56: 241–244.
-
55.
Fryauff DJ, Sumawinata I, Purnomo Richie TL, Tjitra E, Bangs MJ, Kadir A, Ingkokusumo G, 1999. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia. Am J Trop Med Hyg 60: 542–546.
-
56.
Fryauff DJ, Soekartono, Tuti S, Leksana B, Suradi Tandayu S, Baird JK, 1998. Survey of resistance in vivo to chloroquine of Plasmodium falciparum and P. vivax in North Sulawesi, Indonesia. Trans R Soc Trop Med Hyg 92: 82–83.
-
57.
Baird JK, Wiady I, Fryauff DJ, Sutanihardja MA, Leksana B, Widjaya H, Kysdarmanto, Subianto B, 1997. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg 56: 627–631.
-
58.
Taylor WR, Doan HN, Nguyen DT, Tran TU, Fryauff DJ, Gomez-Saladin E, Kain KC, Le DC, Baird JK, 2000. Assessing drug sensitivity of Plasmodium vivax to halofantrine or choroquine in southern, central Vietnam using an extended 28-day in vivo test and polymerase chain reaction genotyping. Am J Trop Med Hyg 62: 693–697.
-
59.
Phan GT, de Vries PJ, Tran BQ, Le HQ, Nguyen NV, Nguyen TV, Heisterkamp SH, Kager PA, 2002. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. Trop Med Int Health 7: 858–864.
-
60.
Marfurt J, de Monbrison F, Brega S, Barbollat L, Müller I, Sie A, Goroti M, Reeder JC, Beck HP, Picot S, Genton B, 2008. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1. J Infect Dis 198: 409–417.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 292 | 266 | 21 |
| Full Text Views | 267 | 10 | 2 |
| PDF Downloads | 61 | 8 | 1 |
In vitro Anti-Malarial Drug Susceptibility of Temperate Plasmodium vivax from Central China
Feng Lu
Feng Lu
Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, China; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand; Department of Parasitology, Bengbu Medical College, Bengbu, Anhui, China; Department of Entomology, The Pennsylvania State University, University Park, Pennsylvania; Department of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Search for other papers by Feng Lu in
Current site
Google Scholar
PubMed
Search for other papers by Feng Lu in
Current site
Google Scholar
PubMed
Qi Gao
Qi Gao
Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, China; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand; Department of Parasitology, Bengbu Medical College, Bengbu, Anhui, China; Department of Entomology, The Pennsylvania State University, University Park, Pennsylvania; Department of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Search for other papers by Qi Gao in
Current site
Google Scholar
PubMed
Search for other papers by Qi Gao in
Current site
Google Scholar
PubMed
Kesinee Chotivanich
Kesinee Chotivanich
Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, China; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand; Department of Parasitology, Bengbu Medical College, Bengbu, Anhui, China; Department of Entomology, The Pennsylvania State University, University Park, Pennsylvania; Department of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Search for other papers by Kesinee Chotivanich in
Current site
Google Scholar
PubMed
Search for other papers by Kesinee Chotivanich in
Current site
Google Scholar
PubMed
Hui Xia
Hui Xia
Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, China; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand; Department of Parasitology, Bengbu Medical College, Bengbu, Anhui, China; Department of Entomology, The Pennsylvania State University, University Park, Pennsylvania; Department of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Search for other papers by Hui Xia in
Current site
Google Scholar
PubMed
Search for other papers by Hui Xia in
Current site
Google Scholar
PubMed
Jun Cao
Jun Cao
Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, China; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand; Department of Parasitology, Bengbu Medical College, Bengbu, Anhui, China; Department of Entomology, The Pennsylvania State University, University Park, Pennsylvania; Department of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Search for other papers by Jun Cao in
Current site
Google Scholar
PubMed
Search for other papers by Jun Cao in
Current site
Google Scholar
PubMed
Rachanee Udomsangpetch
Rachanee Udomsangpetch
Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, China; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand; Department of Parasitology, Bengbu Medical College, Bengbu, Anhui, China; Department of Entomology, The Pennsylvania State University, University Park, Pennsylvania; Department of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Search for other papers by Rachanee Udomsangpetch in
Current site
Google Scholar
PubMed
Search for other papers by Rachanee Udomsangpetch in
Current site
Google Scholar
PubMed
Liwang Cui
Liwang Cui
Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, China; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand; Department of Parasitology, Bengbu Medical College, Bengbu, Anhui, China; Department of Entomology, The Pennsylvania State University, University Park, Pennsylvania; Department of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Search for other papers by Liwang Cui in
Current site
Google Scholar
PubMed
Search for other papers by Liwang Cui in
Current site
Google Scholar
PubMed
Jetsumon Sattabongkot
Jetsumon Sattabongkot
Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, China; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand; Department of Parasitology, Bengbu Medical College, Bengbu, Anhui, China; Department of Entomology, The Pennsylvania State University, University Park, Pennsylvania; Department of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
Search for other papers by Jetsumon Sattabongkot in
Current site
Google Scholar
PubMed
Search for other papers by Jetsumon Sattabongkot in
Current site
Google Scholar
PubMed
In the face of recent increase of Plasmodium vivax malaria in central China, we conducted a study to evaluate in vitro susceptibility of temperate-zone P. vivax parasites to antimalarial drugs. During 2005–2006, in vitro drug susceptibility was measured for 42 clinical P. vivax isolates by using a schizont maturation inhibition technique. Geometric means of 50% inhibitory concentrations (IC50s) and 95% confidence intervals (CIs) were 10.87 (4.50–26.26) ng/mL for chloroquine, 4.21 (1.88–9.42–8) ng/mL for mefloquine, 11.82 (6.20–22.56) ng/mL for quinine, 0.13 (0.09–0.20) ng/mL for artesunate, 18.32 (8.08–41.50) ng/mL for pyrimethamine, and 17.73 (10.29–30.57) ng/mL for piperaquine. The IC50 for chloroquine was lower than those obtained from isolates from Thailand and South Korea, suggesting that chloroquine remained effective against P. vivax malaria in central China. The results further indicated that temperate-zone P. vivax isolates from China were more susceptible to chloroquine, quinine, and mefloquine than isolates from Thailand.
Author Notes
Financial support: This study was supported by the U.S. Military Infectious Diseases Research Program and a grant from the Major State Basic Research Development Program of China (973 Program, No. 2007CB513100).
Authors' addresses: Feng Lu, Qi Gao, and Jun Cao, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu 214064, China, E-mail: gaoqi54@hotmail.com. Kesinee Chotivanich, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Hui Xia, Department of Parasitology, Bengbu Medical College, Bengbu, Anhui 233030, China. Rachanee Udomsangpetch, Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand. Liwang Cui, Department of Entomology, The Pennsylvania State University, University Park, PA. Jetsumon Sattabongkot, Department of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand, E-mail: jetsumon@hotmail.com.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97–106.
-
2.
Guerra CA, Snow RW, Hay SI, 2006. Mapping the global extent of malaria in 2005. Trends Parasitol 22: 353–358.
-
3.
Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti, Elyazar I, Bangs MJ, Maguire JD, Baird JK, 2007. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 77: 984–991.
-
4.
Rodriguez-Morales AJ, Benitez JA, Arria M, 2008. Malaria mortality in Venezuela: focus on deaths due to Plasmodium vivax in children. J Trop Pediatr 54: 94–101.
-
5.
Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, Muller I, 2008. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 5: e127.
-
6.
Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN, 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5: e128.
-
7.
Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, Kochar A, Khatri MP, Gupta V, 2009. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg 80: 194–198.
-
8.
Garnham PC, 1988. Malaria parasites of man: life cycles and morphology (excluding ultrastructure). Wernsdorfer G, McGregor I, eds. Malaria. Principles and Practice of Malariology. London: Churchill Livingstone, 61–96.
-
9.
Baird JK, 2004. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 48: 4075–4083.
-
10.
Baird JK, Hoffman SL, 2004. Primaquine therapy for malaria. Clin Infect Dis 39: 1336–1345.
-
11.
Rieckmann KH, Davis DR, Hutton DC, 1989. Plasmodium vivax resistance to chloroquine? Lancet 2: 1183–1184.
-
12.
Schuurkamp GJ, Spicer PE, Kereu RK, Bulungol PK, Rieckmann KH, 1992. Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans R Soc Trop Med Hyg 86: 121–122.
-
13.
Baird JK, Basri H, Purnomo, Bangs MJ, Subianto B, Patchen LC, Hoffman SL, 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 44: 547–552.
-
14.
Collignon P, 1991. Chloroquine resistance in Plasmodium vivax. J Infect Dis 164: 222–223.
-
15.
Schwartz IK, Lackritz EM, Patchen LC, 1991. Chloroquine-resistant Plasmodium vivax from Indonesia. N Engl J Med 324: 927.
-
16.
Myat Phone K, Myint O, Myint L, Thaw Z, Kyin Hla A, Nwe Nwe Y, 1993. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans R Soc Trop Med Hyg 87: 687.
-
17.
Guthmann JP, Pittet A, Lesage A, Imwong M, Lindegardh N, Min Lwin M, Zaw T, Annerberg A, de Radigues X, Nosten F, 2008. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar. Trop Med Int Health 13: 91–98.
-
18.
Garg M, Gopinathan N, Bodhe P, Kshirsagar NA, 1995. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg 89: 656–657.
-
19.
Dua VK, Kar PK, Sharma VP, 1996. Chloroquine resistant Plasmodium vivax malaria in India. Trop Med Int Health 1: 816–819.
-
20.
Phillips EJ, Keystone JS, Kain KC, 1996. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis 23: 1171–1173.
-
21.
Alecrim Md G, Alecrim W, Macedo V, 1999. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev Soc Bras Med Trop 32: 67–68.
-
22.
de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, Barbosa MG, Alecrim WD, Alecrim MG, 2007. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis 13: 1125–1126.
-
23.
Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedeno N, Dunne M, Berman J, 2001. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg 65: 90–93.
-
24.
Teka H, Petros B, Yamuah L, Tesfaye G, Elhassan I, Muchohi S, Kokwaro G, Aseffa A, Engers H, 2008. Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia. Malar J 7: 220.
-
25.
Lee KS, Kim TH, Kim ES, Lim HS, Yeom JS, Jun G, Park JW, 2009. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg 80: 215–217.
-
26.
Baird JK, 2007. Neglect of Plasmodium vivax malaria. Trends Parasitol 23: 533–539.
-
27.
Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, 2007. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 79–87.
-
28.
Zhou SS, Wang Y, Tang LH, 2007. Malaria situation in the people's republic of China in 2006 [in Chinese]. Chin J Parasitol Parasitic Dis 25: 439–441.
-
29.
Yang XM, Yang MQ, Huang JW, 1996. Clinical research of the sensitivity of Plasmodium vivax to chloroquine [in Chinese]. Chin J Parasitol Parasitic Dis 9: 226–227.
-
30.
Chotivanich K, Silamut K, Udomsangpetch R, Stepniewska KA, Pukrittayakamee S, Looareesuwan S, White NJ, 2001. Ex-vivo short-term culture and developmental assessment of Plasmodium vivax. Trans R Soc Trop Med Hyg 95: 677–680.
-
31.
Russell BM, Udomsangpetch R, Rieckmann KH, Kotecka BM, Coleman RE, Sattabongkot J, 2003. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob Agents Chemother 47: 170–173.
-
32.
Tasanor O, Noedl H, Na-Bangchang K, Congpuong K, Sirichaisinthop J, Wernsdorfer WH, 2002. An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine. Acta Trop 83: 49–61.
-
33.
Chotivanich K, Udomsangpetch R, Chierakul W, Newton PN, Ruangveerayuth R, Pukrittayakamee S, Looareesuwan S, White NJ, 2004. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. Am J Trop Med Hyg 70: 395–397.
-
34.
Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, Prasetyorini B, Piera KA, Barends M, Brockman A, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN, 2007. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS ONE 2: e1089.
-
35.
Chotivanich K, Sattabongkot J, Choi YK, Park JS, Sritabal J, Lim CS, Udomsangpetch R, White NJ, Lee WJ, 2009. Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg 80: 902–904.
-
36.
Russell B, Chalfein F, Prasetyorini B, Kenangalem E, Piera K, Suwanarusk R, Brockman A, Prayoga P, Sugiarto P, Cheng Q, Tjitra E, Anstey NM, Price RN, 2008. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob Agents Chemother 52: 1040–1045.
-
37.
Sharrock WW, Suwanarusk R, Lek-Uthai U, Edstein MD, Kosaisavee V, Travers T, Jaidee A, Sriprawat K, Price RN, Nosten F, Russell B, 2008. Plasmodium vivax trophozoites insensitive to chloroquine. Malar J 7: 94.
-
38.
Pukrittayakamee S, Imwong M, Looareesuwan S, White NJ, 2004. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop 89: 351–356.
-
39.
Putaporntip C, Hongsrimuang T, Seethamchai S, Kobasa T, Limkittikul K, Cui L, Jongwutiwes S, 2009. Differential prevalence of Plasmodium infections and cryptic Plasmodium knowlesi malaria in humans in Thailand. J Infect Dis 199: 1143–1150.
-
40.
Sattabongkot J, Tsuboi T, Zollner GE, Sirichaisinthop J, Cui L, 2004. Plasmodium vivax transmission: chances for control? Trends Parasitol 20: 192–198.
-
41.
Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ, 1991. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337: 1140–1143.
-
42.
Suwanarusk R, Chavchich M, Russell B, Jaidee A, Chalfein F, Barends M, Prasetyorini B, Kenangalem E, Piera KA, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN, 2008. Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. J Infect Dis 198: 1558–1564.
-
43.
Imwong M, Pukrittayakamee S, Pongtavornpinyo W, Nakeesathit S, Nair S, Newton P, Nosten F, Anderson TJ, Dondorp A, Day NP, White NJ, 2008. Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar. Antimicrob Agents Chemother 52: 2657–2659.
-
44.
Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanonta S, White NJ, 1994. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 88: 324–327.
-
45.
Shen JQ, Hu XS, 1978. Comparison of efficacy between long-term oral administration of pyrimethamine and antimalarial pill 3 [in Chinese]. Railway Med J 2: 90–91.
-
46.
Chen JS, Zhang KR, Geng ZW, 1977. Clinical observation on the in vivo sensitivity of Plasmodium vivax to pyrimethamine in Kaifeng District, Henan Province [in Chinese]. Henan J Prev Med 51–56.
-
47.
Auliff A, Wilson DW, Russell B, Gao Q, Chen N, le Anh N, Maguire J, Bell D, O'Neil MT, Cheng Q, 2006. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am J Trop Med Hyg 75: 617–621.
-
48.
Hawkins VN, Auliff A, Prajapati SK, Rungsihirunrat K, Hapuarachchi HC, Maestre A, O'Neil MT, Cheng Q, Joshi H, Na-Bangchang K, Sibley CH, 2008. Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase. Malar J 7: 72.
-
49.
Vijaykadga S, Rojanawatsirivej C, Congpoung K, Wilairatana P, Satimai W, Uaekowitchai C, Pumborplub B, Sittimongkol S, Pinyorattanachote A, Prigchoo P, 2004. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand. Southeast Asian J Trop Med Public Health 35: 566–569.
-
50.
Tasanor O, Ruengweerayut R, Sirichaisinthop J, Congpuong K, Wernsdorfer WH, Na-Bangchang K, 2006. Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand. Trans R Soc Trop Med Hyg 100: 410–418.
-
51.
Baird JK, Sustriayu Nalim MF, Basri H, Masbar S, Leksana B, Tjitra E, Dewi RM, Khairani M, Wignall FS, 1996. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans R Soc Trop Med Hyg 90: 409–411.
-
52.
Baird JK, Sismadi P, Masbar S, Leksana B, Sekartuti, Ramzan A, Tjitra E, 1996. Chloroquine sensitive Plasmodium falciparum and P. vivax in central Java, Indonesia. Trans R Soc Trop Med Hyg 90: 412–413.
-
53.
Fryauff DJ, Tuti S, Mardi A, Masbar S, Patipelohi R, Leksana B, Kain KC, Bangs MJ, Richie TL, Baird JK, 1998. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am J Trop Med Hyg 59: 513–518.
-
54.
Fryauff DJ, Baird JK, Candradikusuma D, Masbar S, Sutamihardja MA, Leksana B, Tuti S, Marwoto H, Richie T, Romzan A, 1997. Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia. Am J Trop Med Hyg 56: 241–244.
-
55.
Fryauff DJ, Sumawinata I, Purnomo Richie TL, Tjitra E, Bangs MJ, Kadir A, Ingkokusumo G, 1999. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia. Am J Trop Med Hyg 60: 542–546.
-
56.
Fryauff DJ, Soekartono, Tuti S, Leksana B, Suradi Tandayu S, Baird JK, 1998. Survey of resistance in vivo to chloroquine of Plasmodium falciparum and P. vivax in North Sulawesi, Indonesia. Trans R Soc Trop Med Hyg 92: 82–83.
-
57.
Baird JK, Wiady I, Fryauff DJ, Sutanihardja MA, Leksana B, Widjaya H, Kysdarmanto, Subianto B, 1997. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg 56: 627–631.
-
58.
Taylor WR, Doan HN, Nguyen DT, Tran TU, Fryauff DJ, Gomez-Saladin E, Kain KC, Le DC, Baird JK, 2000. Assessing drug sensitivity of Plasmodium vivax to halofantrine or choroquine in southern, central Vietnam using an extended 28-day in vivo test and polymerase chain reaction genotyping. Am J Trop Med Hyg 62: 693–697.
-
59.
Phan GT, de Vries PJ, Tran BQ, Le HQ, Nguyen NV, Nguyen TV, Heisterkamp SH, Kager PA, 2002. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. Trop Med Int Health 7: 858–864.
-
60.
Marfurt J, de Monbrison F, Brega S, Barbollat L, Müller I, Sie A, Goroti M, Reeder JC, Beck HP, Picot S, Genton B, 2008. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1. J Infect Dis 198: 409–417.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 292 | 266 | 21 |
| Full Text Views | 267 | 10 | 2 |
| PDF Downloads | 61 | 8 | 1 |